登录
免费注册
首页
论文
论文详情
赞
收藏
引用
分享
科研之友
微信
新浪微博
Facebook
分享链接
A prospective, randomized, double-blind, placebo-controlled Ph1 study to characterize the safety, tolerability, pharmacokinetic/pharmacodynamic profile of NT100, a novel rhG-CSF being developed for use during pregnancy
作者:Kwon P; Carter D; Combs D L; Joing M P; Unutmaz D; Tong J; Swearingen D
来源:
30th Annual Meeting of the European-Society-of-Human-Reproduction-and-Embryology (ESHRE)
, 2014-06-29 to 2014-07-02.
出版日期
2014-7
相似论文
引用论文
参考文献